Expanded international presence boosts Mindray's Q2 sales
This article was originally published in Clinica
Chinese medical device manufacturer Mindray Medical International saw an almost doubling of its Q2 sales, helped by strong performances from both its domestic and newly-expanded international businesses. The Shenzhencompany saw its operations outside of China significantly boosted by the acquisition of Datascope's patient monitoring business in the US and Europe during the quarter (see Clinica No 1299, p 3). Mindray's international sales went up 139% to $87.8m, while the company's performance in China continued to be strong, with sales growing 59% to $57.9m. Total revenue (+99.5%) was$145.7m, while net income increased 55% to $35.2m.